Merus BV • MRUS

Capital at risk.

About Merus BV
Ticker
info
MRUS
Trading on
info
NASDAQ
ISIN
info
NL0011606264
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. Sven Ante Lundberg M.D.
Headquarters
info
Uppsalalaan 17, Utrecht, undefined, Netherlands, 3584 CT
Employees
info
260
Website
info
merus.nl
Merus N.V., a clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes BIZENGRI for the treatment of patients with pancreatic adenocarcinoma or non-small cell lung cancer (NSCLC) and non Neuregulin 1. The company is also developing MCLA-158 for the treatment of solid tumors; MCLA-129 for the treatment of patients with lungs and other solid tumors; ONO-4685 to treat relapsed/refractory T cell lymphoma; and INCA33890 for advanced solid tumors. In addition, it has collaboration agreement with Eli Lilly and Company, Ono Pharmaceutical Co., Ltd., and Betta Pharmaceuticals Co. Ltd. The company was incorporated in 2003 and is headquartered in Utrecht, the Netherlands.
Metrics
BasicAdvanced
Market cap
info
$7.3B
P/E ratio
info
-
EPS
info
-$5.28
Dividend Yield
info
0.00%
Beta
info
1.06
Forward P/E ratio
info
0
EBIDTA
info
$-369M
Ex dividend date
info
-
Price & volume
Market cap
info
$7.3B
Average daily volume
info
1.4M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
0
Trailing P/E
info
0
Price to sales
info
128.93
Price to book
info
9.4
Earnings
EPS
info
-$5.28
EPS estimate (current quarter)
info
-$1.36
EPS estimate (next quarter)
info
-$1.21
EBITDA
info
$-369M
Revenues (TTM)
info
$56.6M
Revenues per share (TTM)
info
$0.80
Technicals
Beta
info
1.06
52-week High
info
$96.28
52-week Low
info
$33.19
50-day moving average
info
$93.50
200-day moving average
info
$63.55
Short ratio
info
0.96
Short %
info
2.02%
Management effectiveness
ROE (TTM)
info
-51.57%
ROA (TTM)
info
-26.53%
Profit margin
info
0.00%
Gross profit margin
info
$20.9M
Operating margin
info
-794.06%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
3.20%
Share stats
Outstanding Shares
info
75.8M
Float
info
69.7M
Insiders %
info
2.28%
Institutions %
info
93.51%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 17 analysts.

Average price target

info
$97.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.49
-$0.90
45.69%
Q4 • 24Beat
-$1.40
-$1.06
-31.63%
Q1 • 25Missed
-$2.23
-$1.14
-95.61%
Q2 • 25Missed
-$1.26
-$1.38
8.70%
Q3 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$7.5M
$-134M
-1,792.23%
Q2 • 25
$10.4M
$-81.6M
-786.17%
Q3 • 25
38.41%
-39.29%
-56.13%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$980M
$138M
14.12%
Q2 • 25
$772M
$110M
14.30%
Q3 • 25
-21.24%
-20.28%
1.22%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-69.2M
$-7.5M
$333M
$-69.3M
Q2 • 25
$-84.9M
-
$6.1M
$-85.2M
Q3 • 25
22.66%
-
-98.16%
22.97%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Merus BV share?
Collapse

Merus BV shares are currently traded for undefined per share.

How many shares does Merus BV have?
Collapse

Merus BV currently has 75.8M shares.

Does Merus BV pay dividends?
Collapse

No, Merus BV doesn't pay dividends.

What is Merus BV 52 week high?
Collapse

Merus BV 52 week high is $96.28.

What is Merus BV 52 week low?
Collapse

Merus BV 52 week low is $33.19.

What is the 200-day moving average of Merus BV?
Collapse

Merus BV 200-day moving average is $63.55.

Who is Merus BV CEO?
Collapse

The CEO of Merus BV is Dr. Sven Ante Lundberg M.D..

How many employees Merus BV has?
Collapse

Merus BV has 260 employees.

What is the market cap of Merus BV?
Collapse

The market cap of Merus BV is $7.3B.

What is the P/E of Merus BV?
Collapse

The current P/E of Merus BV is null.

What is the EPS of Merus BV?
Collapse

The EPS of Merus BV is -$5.28.

What is the PEG Ratio of Merus BV?
Collapse

The PEG Ratio of Merus BV is 0.

What do analysts say about Merus BV?
Collapse

According to the analysts Merus BV is considered a buy.